Received Jul 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNP | MENINGOCOCCAL CONJUGATE (PENMENVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 7J5LF/B | — |
only Meningococcal B liquid component administered; only Meningococcal B liquid component administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 16-year-old female patient who received Men ABCWY NVS (Penmenvy) suspension for injection in pre-filled syringe (batch number 7J5LF/B with expiry date 03-APR-2028) for prophylaxis. On 24-JUN-2026, the patient received Penmenvy. On 24-JUN-2026, an unknown time after receiving Penmenvy, the patient experienced inappropriate dose of vaccine administered (Verbatim: only Meningococcal B liquid component administered) and inappropriate preparation of medication (Verbatim: only Meningococcal B liquid component administered). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.